Related Experiment Video
Updated: Jul 11, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Assessing statistical applications in publications on Alzheimer's disease
Chengjie Xiong1, Yuxiao Tang, Gerald van Belle
1Division of Biostatistics, Washington University, St. Louis, MO 63110, USA. chengjie@wubios.wustl.edu
This study developed tools to assess statistical reporting in Alzheimer's disease (AD) publications. The developed instruments demonstrated feasibility and reliability for evaluating statistical applications in AD research.
Area of Science:
- Biostatistics
- Neuroscience Research Methodology
Background:
- Statistical methods are crucial for the validity of Alzheimer's disease (AD) research.
- Evaluating the quality of statistical applications in AD publications is essential for reliable findings.
Purpose of the Study:
- To develop and validate instruments for assessing statistical reporting in AD publications.
- To determine the feasibility and reliability of these assessment tools.
Main Methods:
- Development of three instruments: Assessment of Statistical Reporting (ASR), Survey of Statistical Designs (SSD), and Survey of Statistical Methods (SSM).
- Pilot testing on 5 AD publications, followed by reliability testing on 30 AD articles and validity testing on 10 AD articles from MEDLINE.
Main Results:
- The ASR demonstrated high test-retest (ICC=0.94) and interrater (ICC=0.84) reliability, with high correlational validity (r=0.74).
- SSD and SSM showed good item-specific test-retest (0.58-1.00) and interrater (0.17-1.00) reliability.
Conclusions:
- The developed instruments are feasible and reliable for assessing statistical applications in Alzheimer's disease publications.
- This evaluation framework can enhance the quality and transparency of statistical reporting in AD research.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
